Erratum (Retracted article): Pharmacokinetic interaction of paeoniflorin and sinomenine: Pharmacokinetic parameters and tissue distribution characteristics in rats and protein binding ability in vitro (Journal of Pharmacological Sciences (2003) 99, (381-391) DOI: 10.1254/jphs.FP0050687);Pharmacokinetic interaction of paeoniflorin and sinomenine: Pharmacokinetic parameters and tissue distribution characteristics in rats and protein binding ability in vitro

Journal of Pharmacological Sciences

Volumn 99, Issue 4, 2005, Pages 381-391

  Zhong, Qiu Liu ^a   Zhi, Hong Jiang ^a   Chan, Kelvin ^a   Zhou, Hua ^a   Yuen, Fan Wong ^a   Zhao, Xiang Bian ^a   Hong, Xi Xu ^b   Liu, Liang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bioavailability; Paeoniflorin; Pharmacokinetics; Sinomenine; Tissue distribution

Indexed keywords

HUMAN ALBUMIN; OROSOMUCOID; PAEONIFLORIN; SINOMENINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; IN VITRO STUDY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; ORGAN DISTRIBUTION; PARAMETER; PLASMA; RAT; TISSUE DISTRIBUTION;

EID: 29144473337     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.RT0994381     Document Type: Erratum

References (29)

1. Yamahara J, Yamada T, Kimura H, Sawada T, Fujimura H. Biologically active principles of crude drugs. II. Anti-allergic principles in "Shoseiryu- To" anti-inflammatory properties of paeoniflorin and its derivatives. J Pharmacobiodyn. 1982;5:921-929.
2. Kimura M, Kimura I, Takahashi K, Muroi M, Yoshizaki M, Kanaoka M, et al. Blocking effects of blended paeoniflorin or its related compounds with glycyrrhizin on neuromuscular junctions in frog and mouse. Jpn J Pharmacol. 1984;36:275-282.
3. Wong LC, Wu LT. [History of Chinese medicine]. 2nd ed. Shanghai: National Quarantine Service; 1936. (in Chinese)
4. Wang Y, Zhou L, Li R. [Study progress in Sinomenium acutum (Thunb.) Rehd. et Wils]. Zhong Yao Cai. 2002;25:209-211. (text in Chinese with English abstract).
5. Yamasaki H. Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama. 1976;30:1-20.
6. Tai Z, Hopkins SJ. Sinomenine: antiarthritic antiinflammatory. Drugs of the Future. 1998;23:45-49.
7. Kok TW, Yue PY, Mak NK, Fan TP, Liu L, Wong RN. The anti-angiogenic effect of sinomenine. Angiogenesis. 2005;8:3-12.
8. Vieregge B, Resch K, Kaever V. Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid. Planta Med. 1999;65:80-82.
9. Liu L, Resch K, Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int J Immunopharmacol. 1994;16:685-691.
10. Kondo Y, Takano F, Yoshida K, Hojo H. Protection by sinomenine against endotoxin-induced fulminant hepatitis in galactosamine-sensitized mice. Biochem Pharmacol. 1994;48:1050-1052.
11. Takeda S, Isono T, Wakui Y, Matsuzaki Y, Sasaki H, Amagaya S, et al. Absorption and excretion of paeoniflorin in rats. J Pharm Pharmacol. 1995;47:1036-1040.
12. Takeda S, Isono T, Wakui Y, Mizuhara Y, Amagaya S, Maruno M, et al. In-vivo assessment of extrahepatic metabolism of paeoniflorin in rats: relevance to intestinal floral metabolism. J Pharm Pharmacol. 1997;49:35-39.
13. Liu ZQ, Zhou H, Liu L, Jiang ZH, Wong YF, Xie Y, et al. Influence of co-administrated sinomenine on pharmacokinetic fate of paeoniflorin in unrestrained conscious rats. J Ethnopharmacol. 2005;99:61-67.
14. Hattori M, Shu YZ, Shimizu M, Hayashi T, Morita N, Kobashi K, et al. Metabolism of paeoniflorin and related compounds by human intestinal bacteria. Chem Pharm Bull. 1985;33:3838-3846.
15. Shu YZ, Hattori M, Akao T, Kobashi K, Kagi K, Fukuyama K, et al. Metabolism of paeoniflorin and related compounds by human intestinal bacteria. II. Structures of 7S- and 7R-paeonimetabolines I and II formed by Bacteroides fragillis and Lactobacillus brevis. Chem Pharm Bull. 1987;35:3726-3733.
16. Heikal OA, Miyashiro H, Akao T, Hattori M. Quantitative determination of paeoniflorin and its major metabolites, paeonimetabolin I , in the rat plasma by enzyme immunoassay. J Trad Med. 1997;14:34-40.
17. Heikal OA, Akao T, Takeda S, Hattori M. Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from paeony roots. Biol Pharm Bull. 1997;20:517-521.
18. Hsiu SL, Lin YT, Wen KC, Hou YC, Chao PD. A deglucosylated metabolite of paeoniflorin of the root of Paeonia lactiflora and its pharmacokinetics in rats. Planta Med. 2003;69:1113-1118.
19. Yan XH, Li HD, Peng WX, Liu FQ, Shao Y, He YQ. [Determination of sinomenine HCl in serum and urine by HPLC and its pharmacokinetics in normal volunteers]. Yao Xue Xue Bao. 1997;32:620-624. (text in Chinese with English abstract)
20. Tsai TH, Wu JW. Regulation of hepatobiliary excretion of sinomenine by P-glycoprotein in Sprague-Dawley rats. Life Sci. 2003;72:2413-2426.
21. Christians U, Kaever VW. Epimorphian compound and its use. US patent 6,372,756. 1999; April 16.
22. Thrivikraman KV, Huot RL, Plotsky PM. Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat. Brain Res Brain Res Protoc. 2002;10:84-94.
23. Liu ZQ, Chan K, Zhou H, Jiang ZH, Wong YF, Xu HX, et al. The pharmacokinetics and tissue distribution of sinomenine in rats and its protein binding ability in vitro. Life Sci. 2005;77:3197-3209.
24. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246-252.
25. De Smet PA, Rivier L. A general outlook on ethnopharmacology. J Ethnopharmacol. 1989;25:127-138.
26. De Smet PA, Brouwers JR. Pharmacokinetic evaluation of herbal remedies. Basic introduction, applicability, current status and regulatory needs. Clin Pharmacokinet. 1997;32:427-436.
27. Barthe L, Woodley J, Houin G. Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol. 1999;13:154-168.
28. Bouer R, Barthe L, Philibert C, Tournaire C, Woodley J, Houin G. The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac. Fundam Clin Pharmacol. 1999;13:494-500.
29. Chan K, Liu ZQ, Jiang ZH, Zhou H, Wong YF, Xu HX, et al. The effects of sinomenine on intestinal absorption of paeoniflorin by everted rat gut sac model. J Ethnopharmacol. In press.